PATENT CLAIM ANALYSIS

Application Number: 16358410
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-07
Patent Classification: ["424", "133100"]

Abstract:
Provided herein are methods of treating B-cell proliferative disorders in particular Follicular Lymphoma and/or Diffuse Large B-Cell Lymphoma using immunoconjugates comprising anti-CD79b antibodies in combination with additional therapeutic agents.

Claim (Index 42):
A method for treating a B-cell proliferative disorder in an individual comprising administering to the individual an effective amount of (a) an immunoconjugate comprising an anti-CD79b antibody linked to a cytotoxic agent, (b) an anti-CD20 antibody, and (c) an alkylating agent.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 99.0
- Lexical Diversity: 1.07143
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13973669', '13760751', '15349964', '11754899', '14960015']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7760845676097398
- 35 USC 102 Novelty (BERT): 0.5833359311690913
- Combined Prediction Score: 0.7568097039656749
- Mean Citation Score: 451.129036
- Max Citation Score: 461.6173
- Similarity Product: 389.7678513693631

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test